<code id='0714D00105'></code><style id='0714D00105'></style>
    • <acronym id='0714D00105'></acronym>
      <center id='0714D00105'><center id='0714D00105'><tfoot id='0714D00105'></tfoot></center><abbr id='0714D00105'><dir id='0714D00105'><tfoot id='0714D00105'></tfoot><noframes id='0714D00105'>

    • <optgroup id='0714D00105'><strike id='0714D00105'><sup id='0714D00105'></sup></strike><code id='0714D00105'></code></optgroup>
        1. <b id='0714D00105'><label id='0714D00105'><select id='0714D00105'><dt id='0714D00105'><span id='0714D00105'></span></dt></select></label></b><u id='0714D00105'></u>
          <i id='0714D00105'><strike id='0714D00105'><tt id='0714D00105'><pre id='0714D00105'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:168
          House Judiciary Chairman Jerrold Nadler (D-NY) listens as Rep. Judy Chu (D-CA) speaks during a news conference.
          Reps. Jerry Nadler (D-N.Y.) and Judy Chu (D-Calif.) Joshua Roberts/Getty Images

          House Democrats are raising concerns with the Biden administration that Medicare Advantage plans need better oversight, citing recent STAT investigations that found insurance companies are using artificial intelligence and algorithmic software to deny care even when people still need it.

          On Friday, Rep. Judy Chu of California and Rep. Jerry Nadler of New York spearheaded a letter to the Centers for Medicare and Medicaid Services asking the agency to step up its oversight of Medicare Advantage insurers. Thirty other House Democrats also signed onto the letter.

          advertisement

          STAT previously reported Medicare Advantage insurers are using proprietary algorithms and AI to initiate payment denials, but that technology does not fully account for someone’s particular care needs. As a result, many frail patients have been kicked out of nursing homes, faced the prospect of draining their savings, or slogged through a long appeals process to get care they and their clinical teams think they need.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Eisai exec who led development of Alzheimer’s drug to retire
          Eisai exec who led development of Alzheimer’s drug to retire

          IvanCheungisretiringaschairmanofEisai'sU.S.operationsandglobalheadofitsAlzheimer’sdiseaseunit.Chanta

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

          MembersofthemediagatheroutsidetheShevchenskivskyicourtduringanewsconferencebyUkraine'sMinisterofInte